Related Experiment Videos
Risk factors for rapid-onset cervical cancer.
A Hildesheim1, O Hadjimichael, P E Schwartz
1National Cancer Institute, Bethesda, Maryland, USA.
American Journal of Obstetrics and Gynecology
|March 17, 1999
Summary
This study investigated rapid-onset cervical cancer identified during Papanicolaou smear screening. Risk factors for rapid-onset cervical cancer appear similar to those for normal-onset disease.
Area of Science:
- Oncology
- Gynecologic Oncology
- Epidemiology
Background:
- Cervical cancer screening via Papanicolaou smears is crucial for early detection.
- Rapid-onset cervical cancer presents a diagnostic challenge during routine screening.
- Understanding risk factors for rapid-onset cervical cancer is essential for targeted prevention and management.
Purpose of the Study:
- To identify risk factors associated with the development of rapid-onset cervical cancer.
- To compare the characteristics of rapid-onset cervical cancer with normal-onset cervical cancer.
- To investigate the role of human papillomavirus (HPV) types in rapid-onset cervical cancer.
Main Methods:
- A case-control study involving 483 women diagnosed with invasive cervical cancer.
- Data collection included Papanicolaou smear screening history, risk factor questionnaires, and physician record reviews.
- Human papillomavirus (HPV) DNA testing and review of prediagnostic Papanicolaou smear slides were performed.
Main Results:
- Rapid-onset cervical cancer cases were younger, more likely to be white, diagnosed with adenocarcinoma/adenosquamous carcinoma, and early-stage disease compared to normal-onset cases.
- HPV DNA was detected in 75.2% of tested cases.
- Human papillomavirus type 18 showed a potential association with rapid-onset disease, but not with possible rapid-onset disease.
Conclusions:
- The risk factors for rapid-onset cervical cancer are similar to those for normal-onset cervical cancer.
- Further research may be needed to fully elucidate specific risk factors and HPV type associations.
- Routine Papanicolaou smear screening remains vital for detecting cervical cancer, including rapid-onset forms.